Diagnostic Dilemmas in Giant Cell Arteritis: Overcoming Anchoring Bias
- PMID: 40726518
- PMCID: PMC12303627
- DOI: 10.1155/crrh/6632374
Diagnostic Dilemmas in Giant Cell Arteritis: Overcoming Anchoring Bias
Abstract
Giant cell arteritis (GCA), also known as temporal arteritis, is the most common systemic vasculitis in individuals over 50 and presents diagnostic challenges due to its nonspecific symptoms such as fever, headache, and fatigue. This case report describes the details of a male patient in his 70s who presented with recurrent intermittent fevers of unknown origin and was ultimately diagnosed with GCA after an extensive workup. His initial CT scans and lab tests were unremarkable. However, after a rheumatological workup displayed elevated erythrocyte sedimentation rate (ESR) and C-reactive protein (CRP) levels, along with new symptoms of ataxia and headaches, a temporal artery biopsy (TAB) was performed and confirmed the patient had GCA. This case underscores the difficulty in diagnosing GCA primarily due to physician anchoring bias, particularly when typical symptoms are not present. The case also showcases the need for increased awareness and prompt evaluation of potential GCA symptoms to prevent severe complications. Public education as well as improved hospital protocols can lead to earlier detection and treatment of GCA, reducing the risk of morbidity.
Keywords: C-reactive protein; fever; fever of unknown origin; giant cell arteritis; temporal artery biopsy.
Copyright © 2025 Crystal Stewart et al. Case Reports in Rheumatology published by John Wiley & Sons Ltd.
Conflict of interest statement
The authors declare no conflicts of interest.
Figures

Similar articles
-
Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19.Cochrane Database Syst Rev. 2022 May 20;5(5):CD013665. doi: 10.1002/14651858.CD013665.pub3. Cochrane Database Syst Rev. 2022. PMID: 35593186 Free PMC article.
-
Systematic review of the literature and a case report informing biopsy-proven giant cell arteritis (GCA) with normal C-reactive protein.Clin Rheumatol. 2012 Sep;31(9):1389-93. doi: 10.1007/s10067-012-2031-3. Epub 2012 Jul 22. Clin Rheumatol. 2012. PMID: 22820967
-
Normal inflammatory markers in giant cell arteritis: a diagnostic blind spot.Rheumatol Int. 2025 Jul 19;45(8):175. doi: 10.1007/s00296-025-05930-3. Rheumatol Int. 2025. PMID: 40682608
-
Polymyalgia Rheumatica and Giant Cell Arteritis: A Systematic Review.JAMA. 2016 Jun 14;315(22):2442-58. doi: 10.1001/jama.2016.5444. JAMA. 2016. PMID: 27299619
-
Giant Cell Arteritis Presenting As Pyrexia of Unknown Origin: Diagnosis Made by Bilateral Periluminal Dark Halo Sign on Color Doppler Ultrasound.Cureus. 2025 Jun 16;17(6):e86134. doi: 10.7759/cureus.86134. eCollection 2025 Jun. Cureus. 2025. PMID: 40672026 Free PMC article.
References
-
- Burg L. C., Karakostas P., Behning C., Brossart P., Kermani T. A., Schäfer V. S. Prevalence and Characteristics of Giant Cell Arteritis in Patients With Newly Diagnosed Polymyalgia Rheumatica—A Prospective Cohort Study. Therapeutic Advances in Musculoskeletal Disease . 2023;15:p. 1759720X221149963. doi: 10.1177/1759720X221149963. - DOI - PMC - PubMed
-
- Ameer M. A., Vaqar S., Khazaeni B. StatPearls . StatPearls Publishing; 2024. Giant Cell Arteritis (Temporal Arteritis) https://www.ncbi.nlm.nih.gov/books/NBK459376/ - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous